Ex Parte Wu - Page 3



          Appeal No. 2003-1315                                                        
          Application No. 09/503,838                                                  

               Claims 1 through 4, 13, 14 and 16 stand rejected under                 
          35 U.S.C. § 103(a) as being unpatentable over Aeba in view of               
          Olowolafe.                                                                  
               Claims 5 and 6 stand rejected under 35 U.S.C. § 103(a) as              
          being unpatentable over Aeba in view of Olowolafe and admitted              
          prior art.                                                                  
               Claims 7 through 10 stand rejected under 35 U.S.C.                     
          § 103(a) as being unpatentable over Aeba in view of Olowolafe and           
          the IBM TDB.                                                                
               Claims 11, 12 and 17 stand rejected under 35 U.S.C.                    
          § 103(a) as being unpatentable over Aeba in view of Olowolafe and           
          Akram.                                                                      
               Reference is made to the briefs (paper numbers 13 and 15)              
          and the answer (paper number 14) for the respective positions of            
          the appellant and the examiner.                                             
                                       OPINION                                        
               We have carefully considered the entire record before us,              
          and we will reverse the 35 U.S.C. § 103(a) rejection of claims              
          1 through 14, 16 and 17.                                                    
               The examiner states (answer, page 4) that “Aeba (US                    
          5,466,956) discloses a method of making and testing a                       
                                          3                                           




Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007